Cargando…

The Gal/GalNac lectin as a possible acetylcholine receptor in Entamoeba histolytica

Entamoeba histolytica (E. histolytica) is a protozoan responsible for intestinal amebiasis in at least 500 million people per year, although only 10% of those infected show severe symptoms. It is known that E. histolytica captures molecules released during the host immune response through membrane r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacheco-Sánchez, Marisol, Martínez-Hernández, Sandra Luz, Muñoz-Ortega, Martín Humberto, Reyes-Martínez, Jesús Alejandro, Ávila-Blanco, Manuel Enrique, Ventura-Juárez, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228505/ https://www.ncbi.nlm.nih.gov/pubmed/37260701 http://dx.doi.org/10.3389/fcimb.2023.1110600

Ejemplares similares

Evidence of Gene Conversion in Genes Encoding the Gal/GalNac Lectin Complex of Entamoeba
por: Weedall, Gareth D., et al.
Publicado: (2011)

Entamoeba histolytica Trophozoites Interact with the c-Met Receptor at the Surface of Liver Origin Cells through the Gal/GalNAc Amoebic Lectin
por: Pérez-Hernández, Jesus, et al.
Publicado: (2021)

Evaluation on Elongation Factor 1 Alpha of Entamoeba histolytica Interaction with the Intermediate Subunit of the Gal/GalNAc Lectin and Actin in Phagocytosis
por: Zhou, Hang, et al.
Publicado: (2020)

Proteomic Identification of S-Nitrosylated Proteins in the Parasite Entamoeba histolytica by Resin-Assisted Capture: Insights into the Regulation of the Gal/GalNAc Lectin by Nitric Oxide
por: Hertz, Rivka, et al.
Publicado: (2014)

Quantitative Proteomics Reveals Metabolic Reprogramming in Host Cells Induced by Trophozoites and Intermediate Subunit of Gal/GalNAc Lectins from Entamoeba histolytica
por: Zhao, Yanqing, et al.
Publicado: (2022)

Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess
por: Min, Xiangyang, et al.
Publicado: (2016)

Overexpression of GalNAc-transferase GalNAc-T3 Promotes Pancreatic Cancer Cell Growth
por: Taniuchi, Keisuke, et al.
Publicado: (2011)

Reduced expression of a rhomboid protease, EhROM1, correlates with changes in the submembrane distribution and size of the Gal/GalNAc lectin subunits in the human protozoan parasite, Entamoeba histolytica
por: Welter, Brenda H., et al.
Publicado: (2020)

Fasciola hepatica Immune Regulates CD11c(+) Cells by Interacting with the Macrophage Gal/GalNAc Lectin
por: Rodríguez, Ernesto, et al.
Publicado: (2017)

Lectin Domains of Polypeptide GalNAc Transferases Exhibit Glycopeptide Binding Specificity
por: Pedersen, Johannes W., et al.
Publicado: (2011)

CNL–Clitocybe nebularis Lectin—The Fungal GalNAcβ1-4GlcNAc-Binding Lectin
por: Sabotič, Jerica, et al.
Publicado: (2019)

Mutagenesis Studies and Structure-function Relationships for GalNAc/Gal-Specific Lectin from the Sea Mussel Crenomytilus grayanus
por: Kovalchuk, Svetlana N., et al.
Publicado: (2018)

Molecular Recognition of GalNAc in Mucin-Type O-Glycosylation
por: Sanz-Martinez, Ignacio, et al.
Publicado: (2023)

Acetylcholine Upregulates Entamoeba histolytica Virulence Factors, Enhancing Parasite Pathogenicity in Experimental Liver Amebiasis
por: Medina-Rosales, Marina Nayeli, et al.
Publicado: (2021)

A GalNAc/Gal-specific lectin from the sea mussel Crenomytilus grayanus modulates immune response in macrophages and in mice
por: Chernikov, Oleg V., et al.
Publicado: (2017)

Expression of alpha-GalNAc glycoproteins by breast cancers.
por: Brooks, S. A., et al.
Publicado: (1995)

The GalNAc-T Activation (GALA) Pathway: Drivers and markers
por: Chia, Joanne, et al.
Publicado: (2019)

Identification of a Gal/GalNAc Lectin in the Protozoan Hartmannella vermiformis as a Potential Receptor for Attachment and Invasion by the Legionnaires' Disease Bacterium
por: Venkataraman, Chandrasekar, et al.
Publicado: (1997)

Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
por: Brown, Christopher R, et al.
Publicado: (2020)

Giardia Cyst Wall Protein 1 Is a Lectin That Binds to Curled Fibrils of the GalNAc Homopolymer
por: Chatterjee, Aparajita, et al.
Publicado: (2010)

Dynamic interplay between catalytic and lectin domains of GalNAc-transferases modulates protein O-glycosylation
por: Lira-Navarrete, Erandi, et al.
Publicado: (2015)

Role of GalNAc4S-6ST in Astrocytic Tumor Progression
por: Kobayashi, Tatsuya, et al.
Publicado: (2013)

Roles of GalNAc-disialyl Lactotetraosyl Antigens in Renal Cancer Cells
por: Tsuchida, Akiko, et al.
Publicado: (2018)

Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
por: Huang, Yuanyu
Publicado: (2017)

Chemoenzymatic modular assembly of O-GalNAc glycans for functional glycomics
por: Wang, Shuaishuai, et al.
Publicado: (2021)

Role of microtubule-associated protein 6 glycosylated with Gal-(β-1,3)-GalNAc in Parkinson's disease
por: Ma, Li, et al.
Publicado: (2019)

Macrophage Gal/GalNAc lectin 2 (MGL2)(+) peritoneal antigen presenting cells during Fasciola hepatica infection are essential for regulatory T cell induction
por: Costa, Monique, et al.
Publicado: (2022)

The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies
por: Janas, Maja M., et al.
Publicado: (2018)

Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models
por: Kim, Youngsoo, et al.
Publicado: (2019)

Polypeptide-GalNAc-Transferase-13 Shows Prognostic Impact in Breast Cancer
por: Fernandez, Eugenia, et al.
Publicado: (2021)

A novel role for GalNAc-T2 dependent glycosylation in energy homeostasis
por: Verzijl, Cristy R.C., et al.
Publicado: (2022)

ABO genotype alters the gut microbiota by regulating GalNAc levels in pigs
por: Yang, Hui, et al.
Publicado: (2022)

Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells
por: Zaal, Anouk, et al.
Publicado: (2020)

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
por: Huang, Jianmei, et al.
Publicado: (2022)

ERK8 is a negative regulator of O-GalNAc glycosylation and cell migration
por: Chia, Joanne, et al.
Publicado: (2014)

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
por: Nair, Jayaprakash K., et al.
Publicado: (2017)

GalNAc-T15 in gastric adenocarcinoma: Characterization according to tissue architecture and cellular location
por: Albuquerque, Mário S. de Souza, et al.
Publicado: (2018)

GalNAc Conjugation Attenuates the Cytotoxicity of Antisense Oligonucleotide Drugs in Renal Tubular Cells
por: Sewing, Sabine, et al.
Publicado: (2018)

Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor
por: Schmidt, Karsten, et al.
Publicado: (2017)

Quantification of Surface GalNAc Ligands Decorating Nanostructured Lipid Carriers by UPLC-ELSD
por: Gauthier, Laura, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6br2e8s6r62cavncmvmfm7pof2